Example: Heart Attack
Search clinical trials for: Dose decrease
Total 7790 results
-
NCT07593898CompletedPersistent Allergic Rhinitis
-
NCT03452579Active, not recruiting
-
NCT05856084Active, not recruiting
-
NCT03882788CompletedNeurodevelopmental Disorders | Congenital Heart Disease | Anesthesia; Adverse Effect
-
NCT02493712Completed
-
NCT01466361CompletedSmoking | Smoking Cessation
-
NCT02426840CompletedHIV Infection | Adverse Bone Health
-
NCT02623036UnknownHypertension, Resistant to Conventional Therapy
-
NCT00670215Completed
-
NCT01430819Completed
-
-
NCT04271332Active, not recruiting16P11.2 Deletion Syndrome
-
NCT00645515Terminated
-
NCT03011645TerminatedCardiovascular Diseases
-
NCT07617298Not yet recruitingARDS (Acute Respiratory Distress Syndrome)
-
NCT05846425RecruitingHyperventilation | Hypoventilation
-
NCT02322086Completed
-
NCT06731413RecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer
-
NCT06238167Not yet recruiting
-
-
NCT05616585CompletedDiet, Healthy | Biological Markers | Nutrition, Healthy | Metabolomics
-
NCT04685109Active, not recruiting
-
NCT06201156CompletedChildhood Asthma With Acute Exacerbation
-
NCT03316638TerminatedAdvanced or Metastatic Solid Tumors
-
NCT05848128CompletedDry Eye Syndromes | Dry Eye Disease | Kerato Conjunctivitis Sicca
-
NCT04597333CompletedInduction of Labor Affected Fetus / Newborn
-
NCT02105922CompletedSarcopenia | Muscle Loss
-
-
NCT01659424Withdrawn
-
NCT03350126Active, not recruiting
-
NCT07490613RecruitingMultiple Myeloma
-
NCT07337772RecruitingAnesthesia, Local | Arthroplasty, Replacement, Knee | Adrenal Cortex Hormones
-
NCT06096051CompletedIntracranial Hemorrhage
-
NCT00781794Withdrawn
-
NCT02782026CompletedPulmonary Hypertension
-
NCT01688427CompletedDomestic Violence | Intimate Partner Violence
-
NCT01260779No longer availableCutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory | Approved Alternative Therapy
-
NCT00669760Completed
-
NCT05751798RecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | NSCLC (Non-small Cell Lung Cancer) | Solid Advanced Tumor
-
NCT07396844Not yet recruiting
-
NCT07204639Not yet recruiting